Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
NCT02194790 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238
Last updated 2014-07-18
Summary
Chronic kidney disease (CKD) is a major health problem in Thailand. Previous studies have demonstrated that integrated pre-dialysis care may slow the decline in renal function (Nephrol Dial Transplant.2009 Nov;24(11):3426-33). It is interesting to know whether early intervention especially in high risk groups like Diabetic may also improve outcome of these patients in primary health care setting resulting in delay of CKD progression.
Conditions
- Chronic Kidney Disease
- Diabetic Nephropathy
Interventions
- BEHAVIORAL
-
Community-based Integrated CKD Care
Patients received, in addition to the standard care, educational activities provided by nutritionist, pharmacist and physiotherapist, and quarterly home visits. Our home visits team consisted of nurse, health care officers and village health volunteers
Sponsors & Collaborators
-
Ministry of Health, Thailand
collaborator OTHER_GOV -
Bhumirajanagarindra Kidney Institute, Thailand
lead OTHER
Principal Investigators
-
Kotcharat Vipattawat, M.D. · Bhumirajanagarindra Kidney Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Metformin in Kidney Disease
NCT02252081 ·Status: COMPLETED ·Phase: PHASE2
-
Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
NCT02176278 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
NCT02065791 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Therapeutic Drug Use for CKD Patients
NCT05818995 ·Status: UNKNOWN
-
Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients
NCT02384902 ·Status: COMPLETED ·Phase: NA
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus
NCT01572610 ·Status: TERMINATED ·Phase: PHASE2
-
Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk
NCT01213212 ·Status: COMPLETED ·Phase: PHASE2
-
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)
NCT01829256 ·Status: COMPLETED ·Phase: NA
-
Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)
NCT02818192 ·Status: RECRUITING
-
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 ·Status: RECRUITING ·Phase: PHASE2
-
Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management
NCT06756113 ·Status: COMPLETED ·Phase: NA
-
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
NCT06182891 ·Status: COMPLETED ·Phase: NA
-
Prevention of Microvascular Complications in Overweight Diabetics With Surgery or Best Medicine
NCT02011178 ·Status: WITHDRAWN ·Phase: NA
-
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
NCT07309094 ·Status: RECRUITING
-
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
NCT06717698 ·Status: RECRUITING ·Phase: PHASE2
-
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis
NCT06031389 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Oxygen Therapy in Diabetic Kidney Disease
NCT06959485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function
NCT00586261 ·Status: TERMINATED ·Phase: NA
-
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
NCT06147232 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
NCT03015480 ·Status: COMPLETED ·Phase: NA
-
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
NCT05349955 ·Status: RECRUITING ·Phase: NA
-
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
NCT01989754 ·Status: COMPLETED ·Phase: PHASE4